UnitedHealth Group (UNH) Cut to Hold at ValuEngine

UnitedHealth Group (NYSE:UNH) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Thursday, December 7th.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, December 1st. BMO Capital Markets began coverage on shares of UnitedHealth Group in a research report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective for the company. Jefferies Group restated a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, Cowen restated an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $224.98.

UnitedHealth Group (UNH) traded down $2.31 on Thursday, hitting $220.46. 2,274,987 shares of the stock traded hands, compared to its average volume of 2,669,704. The stock has a market capitalization of $215,879.17, a P/E ratio of 24.44, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 52-week low of $156.09 and a 52-week high of $231.77.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $2.17 earnings per share. research analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current year.

In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $110,000. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the period. BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the second quarter worth $121,000. Finally, Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Hedge funds and other institutional investors own 86.01% of the company’s stock.

WARNING: This story was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/12/09/valuengine-lowers-unitedhealth-group-unh-to-hold.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply